Shree Pacetronix
- Market cap
- ₹ 59 Cr.
- P/E
- 19.6x
- P/B
- 3.48x
- 52-week range
- 90 – 283.15
- ROE
- 20%
- ROCE
- 23.3%
- Dividend yield
- 0%
- Debt / equity
- 0.15
- Sector
- Healthcare Equipment & Supplies
- Industry
- Medical Equipment & Supplies
- Listed on
- BSE
About
Shree Pacetronix Limited is an India-based company. The Company is mainly engaged in the business of manufacturing pacemakers. The Company operates in one segment, namely, the Life Saving Devices segment. It manufactures different types of pacemakers that include Single chamber pacemaker, Dual chamber pacemaker, and Biventricular pacemaker. Single chamber pacemaker sends electrical signals to the lower right chamber of the heart, whereas Dual chamber pacemaker sends to the upper and lower right heart chambers. The Biventricular pacemaker device stimulates both lower heart chambers. Its products include Pacemakers, Pacing Leads, Pacing System Analyzer and Physician Corner. It offers temporary leads, introducer, Screw-in lead P12 Model 3844 VB/ 3744VB, IS1 Bipolar Lead 3851 VB and Atrial J Bipolar Lead 3851 VB under pacing leads product category. Shree Coratomic Limited is a subsidiary of the Company.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Medical Equipment & Supplies: 25 companies →Shree Pacetronix against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)19.6 against a typical 28.7: cheaper than most peers (1st = cheapest).6th of 25
- Sales growth−8.2% against a typical +21.5% from a year earlier.16th of 18
- Profit growth+15.2% against a typical +13.4% from a year earlier.8th of 16
- Share price, 3 months+23.3% against a typical −7.9%.3rd of 23
- Size₹ 59.1 Cr. market value against a typical ₹ 238.1 Cr. (1st = largest).17th of 24
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5 | 4 | 7 | 5 | 4 | 4 | 4 | 5 | 7 | 4 | 5 | 5 |
| Expenses | 4 | 3 | 4 | 4 | 4 | 3 | 3 | 4 | 5 | 4 | 4 | 4 |
| Operating Profit | 1 | 1 | 2 | 1 | 0 | 0 | 1 | 1 | 2 | 0 | 2 | 1 |
| OPM % | 22% | 19.8% | 36.4% | 16.1% | 10.2% | 3.9% | 22.9% | 21.7% | 30.5% | 9.9% | 30.4% | 24.3% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 1 | 1 | 2 | 1 | 0 | −0 | 1 | 1 | 2 | 0 | 1 | 1 |
| Tax % | 22.1% | 28.6% | 28.7% | 28% | 33.3% | −31.3% | 29.2% | 24.7% | 25.1% | 66.7% | 21.3% | 25.5% |
| Net Profit | 1 | 0 | 1 | 0 | 0 | −0 | 0 | 1 | 1 | 0 | 1 | 1 |
| EPS in Rs | 1.86 | 1.11 | 3.97 | 1.03 | 0.08 | −0.31 | 1.25 | 1.83 | 3.64 | 0.16 | 2.96 | 2.03 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 11%
- 5 Years
- 23%
- 3 Years
- 2%
- TTM
- 23%
- 10 Years
- 43%
- 5 Years
- 129%
- 3 Years
- −1%
- TTM
- 215%
- 10 Years
- 26%
- 5 Years
- 45%
- 3 Years
- −19%
- TTM
- —
- 10 Years
- 14%
- 5 Years
- 21%
- 3 Years
- 18%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Shree Pacetronix | ₹ 169.00 | ₹ 59 Cr. | 19.6x | 3.5x | 20% | — |
| Lenskart Solutions | ₹ 627.55 | ₹ 1,08,959 Cr. | 190.8x | 11.3x | 6.7% | 5.7% |
| Poly Medicure | ₹ 1,446.80 | ₹ 14,582 Cr. | 53.6x | 5.6x | 11% | 17.1% |
| Laxmi Dental | ₹ 171.25 | ₹ 946 Cr. | 35.1x | 4.9x | 12.8% | 9.5% |
| One Global Service Provider | ₹ 372.00 | ₹ 721 Cr. | 15.3x | 7.5x | 65.2% | 14% |
| Mallcom (India) | ₹ 909.00 | ₹ 567 Cr. | 20.3x | 1.9x | — | 5.1% |
Management
- Ashok Atulkar
- Chief Financial Officer, Compliance Officer
- Sumit Chakarbarti
- Chief Operating Officer
- Rupali Ahire
- Compliance Officer, Company Secretary
- Akash Sethi
- Joint Managing Director, Executive Director
- Atul Kumar Sethi
- Managing Director, Executive Director
Prices are delayed and for information only. Nothing on this page is investment advice.